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ABSTRACT Chimeras consisting of the homologous skeletal dihydropyridine receptor (DHPR) b1a subunit and the
heterologous cardiac/brain b2a subunit were used to determine which regions of b1a were responsible for the skeletal-type
excitation-contraction (EC) coupling phenotype. Chimeras were transiently transfected in b1 knockout myotubes and then
voltage-clamped with simultaneous measurement of confocal ﬂuo-4 ﬂuorescence. All chimeras expressed a similar density of
DHPR charge movements, indicating that the membrane density of DHPR voltage sensors was not a confounding factor in
these studies. The data indicates that a b1a-speciﬁc domain present in the carboxyl terminus, namely the D5 region comprising
the last 47 residues (b1a 478–524), is essential for expression of skeletal-type EC coupling. Furthermore, the location of b1aD5
immediately downstream from conserved domain D4 is also critical. In contrast, chimeras in which b1aD5 was swapped by the
D5 region of b2a expressed Ca21 transients triggered by the Ca21 current, or none at all. A hydrophobic heptad repeat is
present in domain D5 of b1a (L478, V485, V492). To determine the role of this motif, residues in the heptad repeat were
mutated to alanines. The triple mutant b1a(L478A/V485A/V492A) recovered weak skeletal-type EC coupling (DF/Fmax ¼ 0.4 6
0.1 vs. 2.7 6 0.5 for wild-type b1a). However, a triple mutant with alanine substitutions at positions out of phase with the heptad
repeat, b1a(S481A/L488A/S495A), was normal (DF/Fmax ¼ 2.1 6 0.4). In summary, the presence of the b1a-speciﬁc D5
domain, in its correct position after conserved domain D4, is essential for skeletal-type EC coupling. Furthermore, a heptad
repeat in b1aD5 controls the EC coupling activity. The carboxyl terminal heptad repeat of b1a might be involved in protein-
protein interactions with ryanodine receptor type 1 required for DHPR to ryanodine receptor type 1 signal transmission.
INTRODUCTION
In skeletal muscle, the (dihydropyridine receptor) DHPR
is responsible for activation of ryanodine receptor type 1
(RyR1) without the intervention of the L-type Ca21 current
(Dirksen andBeam, 1999; Ahern et al., 2001a; Sheridan et al.,
2003b). Ca21 transients persist in low external Ca21, in the
presence of the L-type Ca21 channel antagonist nifedipine,
and when a nonconducting pore mutant, a1S E1014K,
replaces wild-type a1S (Dirksen and Beam, 1999; Ahern
et al., 2001a; Sheridan et al., 2003a,b). From an experimental
perspective, the main characteristic of skeletal-type excita-
tion-contraction (EC) coupling is a sigmoidal relationship
between the amplitude of the Ca21 transient and the
magnitude of the depolarization, with the largest Ca21
transients occurring at large positive potentials (Garcia et al.,
1994; Ahern et al., 2001b). By contrast, Ca21 transients
triggered by the DHPR Ca21 current have a bell-shaped
relationship between the amplitude of the Ca21 transient and
the magnitude of the depolarization, with the largest Ca21
transients occurring at voltages that activate the maximum
Ca21 current (Garcia et al., 1994; Sheridan et al., 2003b). The
voltage dependence of skeletal-type EC coupling is a conse-
quence of the close physical proximity of DHPR and RyR1
channels across the gap separating the transverse tubules and
the junctional sarcoplasmic reticulum. At this location,
groups of four DHPRs arranged in tetrads are lined up with
the foot structure of RyR1. This anatomical feature is only
present in skeletal muscle (Franzini-Armstrong and Protasi,
1997). Tetrads are thought to function as surrogate ‘‘gating
particles’’, which, after acquiring the correct conformation,
open the RyR1 channel (Rios et al., 1993). However, the
molecular basis of the DHPR to RyR1 triggering mechanism
is unknown.
Insights into the EC coupling triggering mechanism have
been provided by studies in which skeletal DHPR subunits
are replaced by heterologous counterparts. A change from
a voltage-dependent skeletal-type EC coupling to a Ca21-
dependent EC coupling was initially described in skeletal
dysgenic (a1S-null) myotubes expressing a1C, the cardiac
pore isoform, instead of a1S, the endogenous isoform
(Tanabe et al., 1990). This observation was used to identify
domains of the a1S pore subunit essential for skeletal-type
EC coupling. The expression of chimeras of a1S and a1C
demonstrated that a domain within the cytosolic loop linking
repeats II and III of a1S, the 720–765 region, was essential
for skeletal-type EC coupling (Nakai et al., 1998a).
However, this domain turned out to be insufﬁcient. Using
a deletion strategy, Ahern et al. (2001a) showed that ;20%
of the skeletal-type Ca21 transient persisted after elimination
of residues 671–690 and 720–765 from the a1S II-III loop.
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Therefore, other regions of the DHPR must participate
directly in opening RyR1. Questions then arise as to where
else in the DHPR to look for skeletal EC coupling domains,
and what strategies to use to identify them.
We have used cultured primary myotubes from knockout
(KO) mice lacking the DHPR b1 gene, which encodes the
b1a isoform expressed in skeletal muscle, to identify
possible EC coupling determinants present in this subunit
(Beurg et al., 1997, 1999a,b; Sheridan et al., 2003a,b).
DHPR b-subunits are tightly bound to a1 pore subunits, and
are inextricably involved in all aspects of Ca21 channel
gating (Birnbaumer et al., 1998). Most important among
them is the observation that b-subunits tighten the coupling
between charge movement and Ca21 channel opening
(Neely et al., 1993; Olcese et al., 1996). Hence, b-subunits
might either directly participate in voltage-sensing, or may
respond to structural changes initiated by the voltage sensor.
Both possibilities are highly relevant to the mechanism of EC
coupling. b1 KO myotubes are phenotypically null for
DHPR Ca21 current and EC coupling; however, the wild-
type (WT) phenotype can be quantitatively recovered by
transient expression of the missing b1a subunit (Beurg et al.,
1997). Studies in b1 KOmyotubes by Sheridan et al. (2003a)
showed that serial truncation of the carboxyl terminus of
DHPR b1a modiﬁes EC coupling, transforming it from
a process controlled by voltage to a much weaker coupling
process controlled by the Ca21 current. This observation is
signiﬁcant since before this work, only exchanges of a1C for
a1S were known to produce Ca21-dependent EC coupling in
skeletal myotubes. Hence, manipulations of a1S and b1a
subunits each independently produced similar outcomes. As
a function of carboxyl terminus truncation length, there was
an overall decrease in the amplitude of Ca21 transients with
evident changes in the shape of the Ca21 ﬂuorescence versus
voltage relationship and the kinetics of the Ca21 transient.
For the most severe truncations, we also observed a de-
pendence of Ca21 transients on external Ca21. These ob-
servations are consistent with the emergence of Ca21-
dependent EC coupling, whereby Ca21 entering the cell via
the DHPR induces sarcoplasmic reticulum Ca21 release,
presumably by Ca21-dependent activation of RyR1 (Sher-
idan et al., 2003b).
Ca21-dependent EC coupling was also promoted in
skeletal myotubes by pairing up the heterologous b2a
variant with the skeletal a1S pore subunit (Sheridan et al.,
2003b). The variance noise characteristics of Ca21 currents
expressed by the heterologous a1S/b2a pair are indistin-
guishable from those expressed by the homologous a1S/b1a
pair (Beurg et al., 1999a). However, b2a overrides critical
EC coupling determinants present in a1S, producing a loss
in voltage-dependent EC coupling (Sheridan et al., 2003b).
The latter was inferred by the drastic reduction in maximum
Ca21 ﬂuorescence at large positive potentials (DF/Fmax) in
double dysgenic/b1 KO myotubes overexpressing both the
pore mutant a1S(E1014K) and b2a (Sheridan et al., 2003b).
Hence, critical interactions of the DHPR with RyR1 are
controlled by conformational states in both a1S and b1a
subunits. Sequence comparison between b1a and b2a
reveals two conserved central regions amounting to more
than half of the total peptide sequence (domains D2 and D4),
a nonconserved linker between the two conserved domains
(D3), a nonconserved amino terminus (D1), and a noncon-
served carboxyl terminus (D5) (Perez-Reyes and Schneider,
1994). Thus, there are three b1a-speciﬁc domains,
namely D1, D3, and D5, that could be required for skeletal-
type EC coupling. In this study, we narrowed the EC coupling
domainofb1ausing chimeras ofb1a andb2a, anddetermined
that a chimera possessing only b1aD5 on a b2a D1–D4
background is sufﬁcient to recapitulate skeletal-type EC
coupling quantitatively. Furthermore, we provide evidence
for the involvement of a heptad repeat in the b1aD5 domain.
Functional studies suggest this heptad repeat may be an
intricate component of the interaction between the DHPR
complex and RyR1. Part of this work has been previously
published in abstract form (Sheridan et al., 2004).
MATERIALS AND METHODS
Identiﬁcation of genotypes
We used polymerase chain reaction (PCR) assays to screen for the WT and
mutant alleles of the DHPR b1 gene in mice with targeted disruption of the
CANCB1 gene (Gregg et al., 1996). Tail samples were digested with
Proteinase K (Sigma, St. Louis, MO), and the DNA was then isolated
following the Puregene animal tissue protocol (Gentra Systems, Minneap-
olis, MN). The PCR reactions for each sample were composed of 11.7 mL
distilled water, 1 mL of each 20 mM primer, 3.2 mL of 1.25 mM dNTPs
(Stratagene, Cedar Creek, TX), 2 mL 103 PCR buffer (Qiagen, Valencia,
CA), 1.2 mL Taq polymerase (Qiagen), and 1 mL of the DNA sample (;100
mg/mL). PCR primers 5# gag aga cat gac aga ctc agc tcg gag a 3# and 5# aca
ccc cct gcc agt ggt aag agc 3# were used to amplify a 250 bp fragment of the
WT b1 allele. PCR primers 5# aca ccc cct gcc agt ggt aag agc 3# and 5# aca
ata gca ggc atg ctg ggg atg 3# were used to amplify a 197 bp fragment of the
KO b1 allele. The following conditions apply for the PCR of both DHPR b1
alleles: 1), 2# at 94C; 2), 30 s at 94C; 3), 45 s at 60C; 4), 1# at 72C; 5),
cycle through steps 2–4 for 30 times; and 6) 10# at 72C.
Primary cultures
Cultures of myotubes were prepared from hind limbs of E18 fetuses, as
described previously (Beurg et al., 1997). Muscles dissected from the fetuses
were treated with 0.125% (w/v) trypsin and 0.05% (w/v) pancreatin. After
centrifugation, mononucleated cells were resuspended in plating medium
containing 78% Dulbeccos’s modiﬁed Eagle’s medium with low glucose,
10% horse serum, 10% fetal bovine serum, and 2% chicken serum extract.
Cells were plated on plastic culture dishes coated with gelatin at a density of
;13 104 cells per dish. Cultures were grown at 37C in 8% CO2 gas. After
myoblast fusion (;6 days), the medium was replaced with fetal bovine
serum free medium, and CO2 was decreased to 5%.
cDNA transfection
cDNA transfection was performed during the myoblast fusion stage with the
polyamine LT1 (Panvera, Madison, WI). Cells were exposed for 2–3 h to
a transfection solution containing LT1 and cDNA at a 5:1 mg ratio. In
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addition to the cDNA of interest, cells were cotransfected with a plasmid
encoding the T-cell protein CD8, which is used as a transfection marker.
Transfected myotubes expressing CD8 were recognized by surface binding
of polystyrene beads coated with a monoclonal antibody speciﬁc for an
external CD8 epitope (Dynal ASA, Oslo, Norway). The efﬁciency of
cotransfection of the marker and the cDNA of interest was ;90%. Whole-
cell analysis of Ca21 currents and Ca21 transients was performed 3–5 days
after transfection.
cDNA constructs
cDNAs for mouse b1a (GenBank accession No. NM_031173), rat b2a
(Genbank accession No. M80545), rat b3 (GenBank accession No.
M88751), and rat b4 (GenBank accession No. L02315) were subcloned
into the pCR-Blunt vector (Invitrogen, Carlsbad, CA), excised by digestion
with AgeI and NotI, and cloned into the pSG5 vector in frame with the ﬁrst
11 residues of the phage T7 gene 10 protein for antibody tagging. All
constructs carry a T7 epitope tag at the amino terminus for determining
relative levels of protein expression in transfected cells.
Chimeric cDNAs
Peptide sequence alignments have identiﬁed ﬁve critical regions in
b-subunits: two central conserved regions (D2 and D4) ﬂanked by three
divergent regions that are heavily spliced (D1, D3, and D5) (Perez-Reyes
and Schneider, 1994). For the construction of chimeras, the boundaries of
domains D1–D5 of mouse b1a and rat b2a were deﬁned on the basis of an
alignment of the peptide sequences performed with DNASTAR software
(DNASTAR, Madison, WI) using the Jotun-Hein method. Sequence
similarities were 41.2%, 78.2%, 36.7%, 90.6%, and 21.7% for domains
D1–D5, respectively. Residue coordinates were as follows: b1aD1,
residues1–57; b1aD2, residues 58–198; b1aD3, residues 199–253;
b1aD4, residues 254–477; b1aD5, residues 478–524; b2aD1, residues 1–
16; b2aD2, residues 17–157; b2aD3, residues 158–205; b2aD4, residues
206–419; and b2aD5, residues 420–604. All cDNAs were made by two-step
PCR techniques. Primers were designed to amplify the 5# end of the chimera
and to introduce an AgeI site at the 5#end of the PCR product. Separate
primers were designed to amplify the 3# end of the chimera and to introduce
a NotI site at the 3# end of the PCR product. The two sets of primers
produced two PCR products with a 17–20 bp overlap of identical sequence.
The two PCR products were electrophoresed on agarose gels, excised from
the gel, and eluted using GenElute columns (SupelCo, Bellefonte, PA). The
two PCR products were mixed in an equimolar ratio, denatured, allowed to
reanneal, and used in a PCR reaction to amplify the full-length chimeric
cDNA bracketed by AgeI and NotI sites. This cDNAwas subcloned in a pCR
2.1 vector, cut with AgeI and NotI enzymes, and fused in frame to the ﬁrst 11
amino acids of the phage T7 gene 10 protein in the pSG5 vector. Residue
coordinates of chimeras are as follows: b2a(D1–D3)/b1a(D4, D5) has
residues 1–207 of b2a fused to residues 254–524 of b1a. b1a(D1–D3)/
b2a(D4, D5) has residues 1–253 of b1a fused to residues 208–604 of b2a.
b2a(D1–D4)/b1aD5 has residues 1–419 of b2a fused to residues 478–524
of b1a. b1a(D1–D4)/b2aD5 has residues 1–477 of b1a fused to residues
430–604 of b2a. b1a(D1–D4)/b1aD5/b2aD5 has residues 1–524 of b1a
fused to residues 430–604 of b2a. b2a(D1–D4)/b2aD5/b1aD5 has residues
1–604 of b2a fused to residues 478–524 of b1a. b1a(D1–D4)/b2aD5/
b1aD5 has residues 1–477 of b1a fused to residues 430–604 of b2a fused to
residues 478–524 of b1a. b2a(D1–D4)/b1aD5/b2aD5 has residues 1–419 of
b2a fused to residues 478–524 of b1a fused to residues 430–604 of b2a.
Heptad repeat mutations
D5ALA has residues 1–524 of mouse b1a with substitutions L478A,
V485A, and V492A. D5ALAc has substitutions S481A, L488A, and
S495A. Constructs were made by two-step PCR techniques, and base
changes for the alanine substitutions were introduced in a single primer. The
PCR product was puriﬁed on QIAquick PCR puriﬁcation columns (Qiagen)
and diluted to 1:10. The ampliﬁed PCR product was subcloned into a pCR
2.1 vector, cut with MluI and SacII, and subcloned into a MluI/SacII
digested pSG5-T7-b1a vector.
Whole-cell voltage clamp
Whole-cell recordings were performed with an Axopatch 200B ampliﬁer
(Axon Instruments, Foster City, CA). Effective series resistance was
compensated up to the point of ampliﬁer oscillation with the Axopatch
circuit. All experiments were performed at room temperature. For Ca21
currents and Ca21 transients, the external solution was (in mM) 130 TEA
methanesulfonate, 10 CaCl2, 1 MgCl2, 10
3 TTX, 10 HEPES titrated with
TEA(OH) to pH 7.4. The pipette solution consisted of (in mM) 140 Cs
aspartate, 5 MgCl2, 0.1 EGTA (when Ca
21 transients were recorded) or 5
EGTA (when only Ca21 currents were recorded), and 10 MOPS titrated
with CsOH to pH 7.2. Patch pipettes had a resistance of 1–3 MV when
ﬁlled with the pipette solution. The limit of Ca21 current detection was
;20 pA/cell or ;0.05 pA/pF for the smallest cells having the lowest
capacitative noise. To obtain Ca21 conductance curves, cells were
maintained at a holding potential of 40 mV and depolarized in ascending
order every 3 s. The pulse duration was 500 ms and was changed in 5 mV
increments up to 185 mV. To obtain Ca21 transient curves, cells were
maintained at 40 mV and depolarized in descending order every 30 s.
The pulse duration was 50 ms or 200 ms and was changed in 20 mV
decrements from 190 mV to 30 mV. Between each depolarization, the
cell was maintained at the resting potential for 30 s to permit recovery of
the resting ﬂuorescence. To obtain charge movement curves, we used
a protocol with a long prepulse to inactivate Na1 channel ionic and gating
currents (Ahern et al., 2001a,b; 2003). The pulse protocol was as follows:
The command voltage was stepped from a holding potential of 80 mV to
30 mV for 698 ms, then to 50 mV for 5 ms, then to the test potential
for 50 ms, then to 50 mV for 50 ms, and then to the 80 mV holding
potential. Test potentials were applied in decreasing order every 10 mV
from 1100 or 1110 mV to 80 mV. The intertest pulse period was 10 s.
Online subtraction of the linear charge was done by a P/4 procedure. The
P/4 pulses were delivered immediately before the pulse protocol from 80
mV in the negative direction. For charge movements, the internal solution
was (in mM) 120 NMG (N-methyl glucamine)-glutamate, 10 HEPES-
NMG, 10 EGTA-NMG pH 7.3 (Ahern et al., 2003). The external solution
was supplemented with 0.5 mM CdCl2 and/or 0.5 mM LaCl3 to block the
Ca21 current, and 0.05 mM TTX to block residual Na1 current.
Confocal ﬂuorescence microscopy
Confocal line scan measurements were performed at room temperature.
Cells were loaded with 5 mM ﬂuo-4 acetoxymethyl ester (Molecular Probes,
Eugene, OR) for 60 min at room temperature. Cells were viewed with an
inverted Olympus microscope with a 203 objective (N.A. ¼ 0.4) and
a Fluoview confocal attachment (Olympus, Melville, NY). A 488 nm
spectrum line for ﬂuo-4 excitation was provided by a 5 mW Argon laser
attenuated to 6% with neutral density ﬁlters. Line scans consisted of 1,000
lines, each of 512 pixels were acquired at a speed of 2.05 milliseconds per
line. The spatial dimension of the line scan was 30–60 microns, and covered
the entire width of the myotube. Locations selected for line scans were
devoid of nuclei and had a low resting ﬂuorescence. Line scans were
synchronized to start 100 ms before the onset of the depolarization. The time
course of the space-averaged ﬂuorescence intensity change and DF/F units
were estimated as described elsewhere (Sheridan et al., 2003a,b). The peak-
to-peak noise in the baseline ﬂuorescence averaged ;0.1 DF/F units. Since
DF/F was spatially averaged, peak-to-peak noise varied with spatial
inhomogeneities in ﬂuo-4 ﬂuorescence and cell size. To construct Ca21
ﬂuorescence versus voltage curves, we used the highest DF/F value attained
DHPR b-EC Coupling 931
Biophysical Journal 87(2) 929–942
between the onset and termination of the voltage pulse. Excessive
photobleaching was avoided by limiting the number of line scans to 14
per cell (7 per each 200-ms and 50-ms curves). Image analyses were
performed with NIH Image software (National Institutes of Health,
Bethesda, MD).
Curve ﬁtting
The voltage dependence of the Ca21 conductance and ﬂuorescence versus
voltage curves with a sigmoidal shape were ﬁtted with a Boltzmann
distribution
A ¼ Amax=ð11 expððV  V1=2Þ=kÞÞ; (1)
where Amax is Gmax or DF/Fmax, V1/2 is the potential at which A ¼ Amax/2,
and k is the slope factor. For myotubes with a bell-shaped ﬂuorescence
versus voltage curve, the peak ﬂuorescence was ﬁt with a modiﬁed
Boltzmann distribution
DF=F ¼ ðV  VrÞ=k#½DF=Fmax=ð11 expðV  V1=2Þ=kÞ;
(2)
where (V  Vr) is a factor that accounts for the decrease in Ca21 current
trigger at positive potentials and k# is a scaling factor that varies with the
magnitude of DF/Fmax (Sheridan et al., 2003a,b). Other parameters are the
same as in Eq. 1. Parameters of a ﬁt of averages of many cells (population
average) are shown in the ﬁgures. Parameters of the ﬁt of individual cells are
shown in the tables. Analysis of variance (ANOVA) was performed with
Analyze-it software (Analyze-it, Leeds, UK).
RESULTS
To identify which heterologous b-subunit would provide the
most suitable background when chimerized with b1a, we
performed a functional screen of variants from the four
mammalian b-genes. Fig. 1 shows Ca21 transients and Ca21
currents at 130 mV, and Ca21 conductance versus voltage
curves expressed by four representative variants in b1 KO
myotubes. In these experiments, the homologous mouse
skeletal muscle b1a (Powers et al., 1992) served as a
reference, and rat heart b2a (Perez-Reyes and Castellano,
1992), rat brain b3 (Castellano et al., 1993a), and rat brain
b4 (Castellano et al., 1993b) were tested as possible
chimeras. All variants, with the exception of b3, recovered a
Ca21 conductance density similar to that recovered by b1a.
The b3 variant was unable to recover a normal charge
movement density (1.26 0.6 vs. 4.26 0.7 fC/pF for b3 and
b1a, respectively; see Table 1 for b1a and b2a), hence b3
was discarded. Only b2a, in addition to the homologous b1a,
was capable of coupling depolarization to a cytosolic Ca21
release. This was inferred from the partial recovery of Ca21
transients observed after b2a overexpression in b1 KO
myotubes. This result indicated that only b2a, among the
heterologous variants, was capable of integrating into an EC
coupling-competent skeletal DHPR. We have previously
estimated that when b1a is replaced by b2a, voltage is;10-
fold less effective as a trigger signal, and furthermore, the
FIGURE 1 Recovery of Ca21 current and Ca21 transients by splice variants of the four b-genes expressed in b1 KO myotubes. Columns show
representative b1 KOmyotubes transfected with skeletal muscle b1a, cardiac/brain b2a, brain b3, and brain b4. GenBank identiﬁcation numbers are indicated
in Materials and Methods. Top trace corresponds to the spatial integral of the confocal Ca21 transient in DF/F units in response to a 200 ms depolarization to
130 mV from a holding potential of 40 mV. The Ca21 current during the 200-ms depolarization is shown expanded. Note change in amplitude scale for the
time course of ﬂuorescence. Bottom shows Ca21 conductance versus voltage curves for population averages in response to a 500-ms depolarization in 5 mV
increments from35 to160 mV. The shaded line in all ﬁgures shows the average Ca21 conductance of nontransfected b1 KOmyotubes. Curves were ﬁt with
Eq. 1 with the following parameters (Gmax in pS/pF, V1/2 in mV, and k in mV, respectively). For b1a: 194, 14.9, and 7.0; for b2a: 183, 11.6, and 5.2; for b3: 40,
40.2, and 28.1; and for b4: 171, 16.9, and 7.0.
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bulk of the Ca21 transient induced by b2a is due to cytosolic
Ca21 increase triggered by the Ca21 current (Sheridan et al.,
2003b). Because there may be numerous reasons for the
inability of b4 to recover EC coupling, we opted for the more
conservative approach, which was to utilize b2a as the
backbone for our chimeras.
Chimeras are identiﬁed by their domain content (b1a or
b2a domains D1–D5), listing ﬁrst the domain content of the
amino terminus followed by the domain content nearest to
the carboxyl terminus. The boundaries of domains D1–D5 of
both variants, and the amino acid coordinates of each
chimera, appear in Materials and Methods. We tested two
complementary chimeras with a C-terminal half belonging to
b1a or b2a, namely b2a(D1–D3)/b1a(D4, D5) and b1a(D1–
D3)/b2a(D4, D5), and two complementary chimeras with
domain D5 belonging to b1a or b2a, namely b2a(D1–D4)/
b1aD5 and b1a(D1–D4)/b2aD5. The interaction between
the pore-forming subunit of the Ca21 channel and the
b-subunit promotes trafﬁcking of the DHPR complex to the
plasma membrane (Chien et al., 1995; Bichet et al., 2000).
To estimate the density of DHPR voltage sensors expressed
by each chimera, we used a charge movement protocol. The
top panels of Fig. 2 show charge movements expressed by
the four tested chimeras using a protocol that isolated the
charge movements produced by the expressed DHPR from
those generated by other voltage-gated channels present in
myotubes (Ahern et al., 2001a,b). The graphs in Fig. 2 show
charge versus voltage relationships for the four tested
constructs obtained by integration of the OFF component,
which usually was less contaminated by ionic current than
the ON component. The voltage dependence of the mean
charge was ﬁt in each case to a Boltzmann equation (Eq. 1)
indicated by the solid line. The experimental maximum
charge detected at large positive potentials was within 10%
of the ﬁtted Qmax, indicating that the chosen range of test
pulses was adequate to detect the bulk of the nonlinear
charge movements. In all cases, the Qmax was signiﬁcantly
larger than the background Qmax of nontransfected cells, as
conﬁrmed by ANOVA (Table 1). High signiﬁcance was
attached to the fact that the mean Qmax of cells expressing the
different chimeras were not signiﬁcantly different from the
mean Qmax expressed by WT b1a (Table 1). This indicated
that the b1a or b2a content of the chimeras did not
selectively affect the voltage-sensing properties of the
FIGURE 2 Charge movements and Ca21 conductance expressed by b1a-b2a chimeras in b1 KO myotubes. Chimeras were identiﬁed according to the
source, b1a or b2a, of the ﬁve domains (D1, D2, D3, D4, and D5). Boundaries for each domain were obtained from a sequence lineup described in Materials
and Methods. In the block diagram representation of the chimeras, shaded is b2a and black is b1a. The shaded line in all graphs shows the average charge
movement or Ca21 conductance of nontransfected b1 KO myotubes. Charge movement curves were ﬁt with Eq. 1 with the following parameters (Qmax in
fC/pF, V1/2 in mV, and k in mV, respectively). For b2a(D1–D3)/b1a(D4, D5): 4.0, 32.5, and 19.7; for b1a(D1–D3)/b2a(D4, D5): 4.7, 33.3, and 20.9;
for b2a(D1–D4)/b1aD5: 3.5, 6.8, and 11.5; for b1a(D1–D4)/b2aD5: 3.9, 9.3, and 18.2; and for nontransfected b1 KO myotubes: 1.8, 5.2, and 17. Ca21
conductance curves were ﬁt with Eq. 1 with the following parameters (Gmax in pS/pF, V1/2 in mV, and k in mV, respectively). For b2a(D1–D3)/b1a(D4,
D5): 204, 9.9, and 6.0; for b1a(D1–D3)/b2a(D4, D5): 63, 15.2, and 5.3; for b2a(D1–D4)/b1aD5: 181, 5.5, and 5.0; for b1a(D1–D4)/b2aD5: 42, 14.6, and 6.2;
and for nontransfected b1 KO myotubes: 20, 20, and 14.
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DHPR, or the trafﬁcking of the DHPR complex to the cell
surface.
Ca21 conductance versus voltage curves expressed by the
chimeras are shown in the bottom panels of Fig. 2, and
a statistical analysis of this data is shown in Table 2. We
found that the chimeras with a carboxyl terminus belonging
to b1a expressed a high Ca21 conductance density similar to
that expressed by WT b1a or WT b2a (see Table 2). In
contrast, the reverse chimeras with a carboxyl terminus
belonging to b2a, namely b1a(D1–D3)/b2a(D4, D5), and
b1a(D1–D4)/b2aD5, expressed a Ca21 conductance three-
to fourfold lower than the chimeras that included b1aD5.
Even though the behavior of the low-conductance chimeras
was different from that of both parent variants, the results
were consistent with a previous study of the structural de-
terminants present in b-subunits for Ca21 current ex-
pression in skeletal myotubes (Ahern et al., 2003). We
have shown that WT b2a derives its ability to express high-
density Ca21 currents from a unique double cysteine motif
present in domain D1. In contrast, WT b1a derives its ability
to express high-density Ca21 currents from domain D5, and
deletion of this domain leads to a signiﬁcant loss in Ca21
current expression (Ahern et al., 2003; Sheridan et al.,
2003a). Chimeras b1a(D1–D3)/b2a(D4, D5), and b1a(D1–
D4)/b2aD5 have neither domains b2aD1 nor b1aD5, and
thus, Ca21 current expression by these chimeras is predicted
to be minimal due to the absence of the required structural
elements. Chimeras b2a(D1–D3)/b1a(D4, D5) and b2a(D1–
D4)/b1aD5 have both domains required for Ca21 current
expression, hence Ca21 current expression by these chimeras
was predicted to be entirely normal.
Fig. 3 shows Ca21 ﬂuorescence versus voltage curves of
the four chimeras investigated determined by two separate
pulse protocols. Prior studies showed that Ca21 transients
can be readily evoked in cultured myotubes by a 50-ms
depolarization, which is adequate for completion of charge
movements in the DHPR (Ahern et al., 2001a,b). However,
the L-type Ca21 current expressed by the DHPR evolves
much more slowly and is not fully activated at the end of a 50
ms pulse. To determine a possible contribution of the Ca21
current to the EC coupling recovered by the chimeras, we
compared Ca21 transients activated by depolarizations
lasting 50 ms (solid symbols) and 200 ms (open symbols).
As shown in the top row of Fig. 3, the two chimeras
possessing domain D5 of b1a produced Ca21 transients that
increased in a sigmoidal manner with voltage, with the
amplitude peaking at potentials more positive than 130 mV
in both pulse protocols. Both features, namely the absence of
pulse duration dependence and persistence at large positive
potentials, are hallmarks of skeletal-type EC coupling, and
have been veriﬁed for the case of b1 KO myotubes
expressing WT b1a (Table 3). In contrast, the chimera that
included domains D4 and D5 of b2a shown in the bottom
row of Fig. 3, namely b1a(D1–D3)/b2a(D4, D5), expressed
Ca21 transients with a drastically reduced DF/Fmax. Ca
21
transients of a small magnitude were detected at ;130 mV
with the 200 ms depolarization, but not with the 50 ms
stimulus. Furthermore, the largest Ca21 transients coincided
with the maximum Ca21 current. The bell-shaped ﬂuores-
cence curve observed with the 200 ms depolarization is
indicative of Ca21-dependent EC coupling previously
described for WT b2a (Sheridan et al., 2003b). However,
TABLE 2 Ca21 conductance expressed by domain chimeras
and heptad repeat mutants in b1 KO myotubes
G-V
Gmax (pS/pF) V1/2 (mV) k (mV)
WT b1a 195 6 23 (10) 15 6 2 4.5 6 0.6
WT b2a 184 6 36 (6) 11 6 1 5.1 6 0.3
b2a(D1–D3)/b1a(D4, D5) 223 6 17 (19) 12 6 1 4.2 6 0.4
b1a(D1–D3)/b2a(D4, D5) 63 6 6* (20) 16 6 1 4.9 6 0.3
b2a(D1–D4)/b1aD5 158 6 31 (9) 7 6 2 4.4 6 0.4
b1a(D1–D4)/b2aD5 48 6 12* (7) 21 6 3 6.1 6 0.8
b2a(D1–D4)/b2aD5/b1aD5 193 6 38 (8) 17 6 2 4.9 6 0.6
b2a(D1–D4)/b1aD5/b2aD5 174 6 28 (7) 11 6 2 3.1 6 0.4
b1a(D1–D4)/b1aD5/b2aD5 180 6 20 (7) 18 6 2 5.4 6 0.6
b1a(D1–D4)/b2aD5/b1aD5 71 6 14 (6) 20 6 2 5.0 6 0.3
D5ALA (L478A,
V485A, V492A)
121 6 18 (8) 23 6 4 4.4 6 0.3
D5ALAc (S481A,
L488A, S495A)
134 6 16 (8) 23 6 2 5.0 6 0.2
Nontransfected b1 KO 20 6 5* (10) 20.3 6 7 14 6 2.2*
Mean 6 SEM of Boltzmann parameters ﬁtted to each cell with number of
cells in parenthesis. Gmax, V1/2, and k are parameters of the Boltzmann ﬁt to
each cell with Eq. 1.
*Parameters in each column compared to WT b1a with one-way ANOVA
signiﬁcance p , 0.05. Data for WT b1a and WT b2a are from Sheridan
et al. (2003b).
TABLE 1 Charge movements expressed by domain chimeras
and heptad repeat mutants in b1 KO myotubes
Q-V
Qmax (fC/pF) V1/2 (mV) k (mV)
WT b1a 4.2 6 0.7* (4) 24.7 6 5.2 20.1 6 1.9
WT b2a 3.5 6 0.6* (8) 15.4 6 7.8 19.0 6 1.7
b2a(D1–D3)/b1a(D4, D5) 4.0 6 0.7* (4) 26 6 6 16.6 6 2.5
b1a(D1–D3)/b2a(D4, D5) 4.5 6 0.4* (5) 30 6 2 19.7 6 0.4
b2a(D1–D4)/b1aD5 3.5 6 0.1* (5) 10 6 11 16.8 6 3.5
b1a(D1–D4)/b2aD5 4.0 6 0.1* (4) 11 6 6 17.9 6 1.9
D5ALA (L478A,
V485A, V492A)
3.8 6 0.7* (4) 15 6 3 18.1 6 2.5
D5ALAc (S481A,
L488A, S495A)
3.9 6 0.6* (4) 13 6 8 17.3 6 2.6
Nontransfected b1 KO 1.8 6 0.16y (5) 16 6 5 11.6 6 3.1
Mean 6 SEM of Boltzmann parameters ﬁtted to each cell with number of
cells in parenthesis. Qmax, V1/2, and k are parameters of the Boltzmann ﬁt to
each cell with Eq. 1.
*Parameters in each column compared to nontransfected cells with one-way
ANOVA signiﬁcance p , 0.05.
yParameters in each column compared to WT b1a with one-way ANOVA
signiﬁcance p , 0.05. Data for WT b1a and WT b2a are from Ahern et al.
(2003).
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the reduced magnitude of the Ca21 transients at all potentials
prevented us from further testing this possibility. The
chimera that included domain D5 of b2a on a background
of domains D1–D4 of b1a, labeled b1a(D1–D4)/b2aD5,
was entirely inactive. This result is consistent with the fact
that b1a(D1–D4)/b2aD5 expressed minimal Ca21 current,
and thus, Ca21-dependent EC coupling expressed by this
chimera might be too small to be detected. In summary, the
behavior of the chimeras demonstrated the critical in-
volvement of the D5 region of b1a in skeletal-type EC
coupling. Absence of b1aD5 leads to severe changes in the
magnitude and voltage dependence of Ca21 transients, or in
the case of b1a(D1–D4)/b2aD5, to a complete loss of Ca21
transients activated by depolarization. Moreover, other
unique domains of b1a, namely D1 and D3, do not appear
to be directly required for this signaling mechanism since
they could be swapped by b2a(D1–D3) without impinging
on the voltage-dependent characteristics of the ﬂuorescence
versus voltage curve. Fig. 4 shows that the EC coupling
expressed by the two chimeras with domain D5 belonging to
b1a, namely b2a(D1–D3)/b1a(D4, D5) and b2a(D1–D4)/
b1aD5, persisted after the Ca21 current was blocked by
nifedipine. In these experiments, the pulse duration was 200
ms, and the same myotube was subjected to stimulation in
control external solution, and in external solution supple-
mented with nifedipine. In all cases, perfusion of cells with
external solution containing 2.5 mM nifedipine abolished the
Ca21 current to a level below detection (shaded traces),
which was;20 pA/cell. In b1 KO myotubes overexpressing
WT b1a, ;40% of the Ca21 transient was resistant to
nifedipine, consistent with previous studies in normal
cultured skeletal myotubes (Nakai et al., 1998a; Wilkens
et al., 2001). The ﬂuorescence versus voltage plots show that
the Ca21 transients in the b1aD5-containing chimeras were
resistant to nifedipine by an equal or better margin. Nifed-
ipine has been shown to negatively effect charge movement
in the DHPR (Rios and Brum, 1987), and this could ex-
plain the partial decrease in Ca21 transient amplitude
seen in WT b1a and the two chimeras. The observations
conﬁrmed the presence of voltage-dependent skeletal-type
EC coupling in the b2a(D1–D3)/b1a(D4, D5) and b2a(D1–
D4)/b1aD5 chimeras.
Since chimeras with domain D5 of b2a had weak Ca21
current expression and lacked skeletal-type EC coupling
function, we investigated whether b2aD5 had a dominant
negative effect on the function of the subunit. This was
achieved by fusing a tandem of b1aD5 and b2a D5 to the
carboxyl terminus of domains D1–D4. Fig. 5 shows the
Ca21 conductance and EC coupling behavior of four
chimeras designed on the basis of the order of b1aD5 and
b2aD5 in the tandem and the source of domains D1–D4. A
chimera with b2aD5 was fused to the carboxyl terminus of
full-length b1a, labeled b1a(D1–D4)/b1aD5/b2aD5, ex-
pressed a normal Ca21 conductance, and furthermore, the
ﬂuorescence versus voltage curve had a sigmoidal shape
with a DF/Fmax only slightly lower than that expressed by
WT b1a control and b2a(D1–D4)/b1aD5 (Table 3). In these
experiments, we used the protocol described in Fig. 3
consisting of depolarizations for 50 ms (solid symbols) and
200 ms (open symbols). We found that for the b1a(D1–D4)/
b1aD5/b2aD5 chimera, pulse duration had no impact in the
shape of the ﬂuorescence versus voltage relationship. Hence,
fusion of the b2aD5 region to an otherwise full-length b1a
subunit did not alter the skeletal-type EC coupling behavior
of the b1a subunit. Conversely, domain D5 of b1a could
have a dominant positive effect on b2a, which would lead to
the expression of skeletal-type EC coupling. A chimera with
b1aD5 was fused to the carboxyl terminus of full-length b2a,
labeled b2a(D1–D4)/b2aD5/b1aD5, expressed a high-den-
sity Ca21 conductance; however, skeletal-type EC coupling
was not recovered. The bell-shaped ﬂuorescence versus
voltage curve expressed by b2a(D1–D4)/b2aD5/b1aD5 was
FIGURE 3 Ca21 transients expressed by b1a-b2a chimeras in b1 KO
myotubes. Open symbols correspond to peak DF/F obtained with a 200-ms
depolarization and solid symbols were obtained with a 50-ms depolarization.
Except for b1a(D1–D4)/b2aD5, the lines correspond to a Boltzmann ﬁt of
the mean (peak DF/F) for the population of cells. For b1a(D1–D4)/b2aD5,
the lines are an interpolation of the mean at each potential. All ﬂuorescence
versus voltage curves were ﬁt with Eq. 1, except those obtained with the 200
ms depolarization in the bottom row, which were ﬁt with Eq. 2. Curves were
ﬁt with the following parameters (DF/Fmax in DF/F units, V1/2 in mV, and k
in mV, respectively). For b2a(D1–D3)/b1a(D4, D5): 2.5,5.5, 8.4 (50 ms),
and 2.9, 7.1, 8.0 (200 ms); for b2a(D1–D4)/b1aD5: 2.3, 2.8, 5.8 (50 ms)
and 2.5, 1.5, 5.5 (200 ms); and for b1a(D1–D3)/b2a(D4, D5): 0.2, 16.3,
13.4 (50 ms) and 0.9, 11.1, 1.9 (200 ms).
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consistent with Ca21-dependent EC coupling, and was
similar to that expressed by full-length b2a (Sheridan et al.,
2003b). Hence, neither b1aD5 nor b2aD5 could signiﬁ-
cantly alter the function of an intact b-subunit when the
heterologous D5 domain was fused downstream from the
homologous D5 domain. These results ruled out a simple
dominant negative effect of b2aD5, or a dominant positive
effect of b1aD5. However, the position of b1aD5 next to D4
turned out to be an important factor for the EC coupling
function of the subunit. This was inferred from the behavior
of chimeras in which the order of b1aD5 and b2aD5 in the
tandem was changed. The chimera labeled b2a(D1–D4)/
b1aD5/b2aD5 consisted of a b2a(D1–D4) backbone with
b1aD5 fused next to b2aD4 followed by the b2aD5 domain.
Fig. 5 shows that this chimera expressed a normal Ca21
current density, and furthermore, the ﬂuorescence versus
voltage characteristics were sigmoidal in shape irrespective
of pulse duration. Thus, by moving b1aD5 from the carboxyl
terminus of b2a to a location next to b2aD4, we observed
a gain of skeletal EC coupling function. The chimera labeled
b1a(D1–D4)/b2aD5/b1aD5 consisted of a b1a(D1–D4)
backbone and the heterologous b2aD5 domain fused to the
TABLE 3 Ca21 transients expressed by domain chimeras and heptad repeat mutants in b1 KO myotubes
50 ms F-V 200 ms F-V
DF/Fmax V1/2 (mV) k (mV) DF/Fmax V1/2 (mV) k (mV)
WT b1a 2.7 6 0.5 (10) 3 6 2 7.7 6 0.5 3.4 6 0.6 (10) 8 6 2 5.8 6 1.1
WT b2a 0.9 6 0.2* (10) 2 6 3 7.4 6 1.5 1.7 6 0.4* (10) 6 6 3 7.6 6 1.9
b2a(D1–D3)/b1a(D4, D5) 2.8 6 0.6 (8) 2 6 3 7.8 6 1.1 2.9 6 0.4 (9) 7 6 3 5.9 6 1.2
b1a(D1–D3)/b2a(D4, D5) 0.2 6 0.1* (7) 24 6 11* 23.0 6 4.1* 0.7 6 0.1* (6) 14 6 2* 6.5 6 2.1
b2a(D1–D4)/b1aD5 2.4 6 0.5 (8) 4 6 3 8.2 6 1.8 2.6 6 0.6 (9) 4 6 2 4.8 6 1.3
b1a(D1–D4)/b2aD5  (5)    (5)  
b2a(D1–D4)/b2aD5/b1aD5 0.3 6 0.1* (11) 6 6 4 15.2 6 3.2 1.0 6 0.3* (11) 12 6 3* 7.6 6 1.2
b2a(D1–D4)/b1aD5/b2aD5 2.2 6 0.4 (5) 18 6 5 9.6 6 2.1 2.5 6 0.8 (5) 8 6 6 7.2 6 2.7
b1a(D1–D4)/b1aD5/b2aD5 1.9 6 0.5 (9) 12 6 3 12.0 6 1.7 2.2 6 0.2 (7) 11 6 4 10.2 6 1.6
b1a(D1–D4)/b2aD5/b1aD5 0.4 6 0.1 (3/7) 17 6 11 19.2 6 1.7 0.5 6 0.1* (5) 11 6 4 9.4 6 2.1
D5ALA (L478A, V485A, V492A) 0.4 6 0.1* (8) 12 6 3 20.0 6 4.3 0.7 6 0.2* (8) 15 6 5 11.4 6 2.2
D5ALAc (S481A, L488A, S495A) 2.1 6 0.4 (7) 14 6 2 7.2 6 1.7 2.6 6 0.5 (7) 16 6 5* 9.1 6 3.4
Mean 6 SEM of Boltzmann parameters ﬁtted to each cell with number of cells in parentheses. Parameters of ﬂuorescence versus voltage curves are shown
for 50 ms and 200 ms depolarizations. DF/Fmax, V1/2, and k are parameters of the Boltzmann ﬁt to each cell. All data was ﬁt with Eq. 1 except ﬂuorescence
data in response to 200 ms in cells expressing b1a(D1–D3)/b2a(D4, D5), b2a(D1–D4)/b2aD5/b1aD5, and b1a(D1–D4)/b2aD5/b1aD5, which were ﬁt with
Eq. 2.
*Parameters in each column compared to WT b1a with one-way ANOVA signiﬁcance p , 0.05. Data for WT b1a and WT b2a are from Sheridan et al.
(2003b).
FIGURE 4 Nifedipine-insensitive Ca21 transients ex-
pressed by b1a-b2a chimeras in b1 KO myotubes.
Columns show representative b1 KO myotubes ex-
pressing full-length WT b1a, b2a(D1–D3)/b1a(D4,
D5), and b2a(D1–D4)/b1aD5. Myotubes were depolar-
ized for 200 ms from a holding potential of 40 mV to
130 mV in standard external solution containing 10 mM
Ca21. Ca21 transients and Ca21 currents were measured
in the same myotube before and after (shaded traces)
inhibition of the Ca21 current by 2.5 mM nifedipine
added to the external solution. Ca21 currents during the
200 ms depolarization are shown expanded. Graphs
show peak DF/F versus voltage relationships before and
after (shaded symbols) nifedipine inhibition.
936 Sheridan et al.
Biophysical Journal 87(2) 929–942
carboxyl terminus followed by the homologous b1aD5
domain. This chimera expressed minimal Ca21 current and
EC coupling. Thus, by simply moving b1aD5 away from its
homologous location next to b1aD4, we observed a loss of
skeletal EC coupling function. From these domain swapping
approaches, we concluded that b1aD5 derives its ability to
dictate skeletal-type EC coupling function from its position
in the linear sequence immediately downstream from do-
mains D1–D4. However, the composition of D1–D4, either
from b1a or b2a, is not critical.
We further determined speciﬁc amino acids in b1aD5 that
contributed to skeletal-type EC coupling. A prior study
based on serial truncation of the D5 region suggested that
b1a residues 464–503 were critical (Sheridan et al., 2003a).
This region contains a hydrophobic heptad repeat L478-
V485-L492, which is a protein motif typically encountered
in protein-protein interactions affecting gating (McCormack
et al., 1991; Garcia et al., 1997) and RyR1 channel kinase/
phosphatase interactions (Marx et al., 2001). Furthermore,
this heptad repeat is not present in D5 domains of other
b-subunit genes (Perez-Reyes and Schneider, 1994). The top
sequences in Fig. 6 show the mutation scheme utilized to test
the functional signiﬁcance of the heptad repeat of b1aD5.
We mutated the three positions in the heptad repeat to
alanines (L478A/V487A/L492A), and as a control, in-
troduced alanines at three positions out of step with the
heptad repeat (S481A/L488A/S495A). The middle row
shows Ca21 conductance versus voltage curves for the triple
heptad repeat mutant (D5ALA) and the control triple mutant
(D5ALAc). The D5ALA and control mutations produced
a slight reduction in Ca21 conductance compared to WT b1a
(shaded line). However, the difference was not statistically
signiﬁcant (see Table 2). Furthermore, charge movements
expressed by D5ALA and the control triple mutant were not
signiﬁcantly different from the charge movements expressed
by WT b1a (see Table 1). The bottom row of Fig. 6 shows
that D5ALAc recovered nearly normal Ca21 transient
compared to WT b1a. The Boltzmann ﬁt shown by the
shaded line corresponds to the ﬁt of WT b1a from the left
panel of Fig. 6. Open symbols correspond to Ca21 transients
in response to a 200 ms depolarization, and solid symbols are
in response to 50 ms. D5ALAc displayed a lack of pulse
FIGURE 5 Ca21 conductance and Ca21 transients expressed by b1a-b2a chimeras with domain D5 in different positions. Columns show the functional
behavior chimeras with a C-terminus corresponding to a tandem of b1aD5 and b2aD5 domains expressed in b1 KO myotube. Ca21 conductance curves were
ﬁt with Eq. 1 with the following parameters (Gmax in pS/pF, V1/2 in mV, and k in mV, respectively). For b2a(D1–D4)/b2aD5/b1aD5: 192, 16.7, and 5.5; for
b2a(D1–D4)/b1aD5/b2aD5: 175, 11.9, and 4.4; for b1a(D1–D4)/b2aD5/b1aD5: 71, 19.4, and 5.3; and for b1a(D1–D4)/b1D5/b2aD5: 177, 18.5, and 6.8. For
ﬂuorescence curves, open symbols correspond to peak DF/F obtained with a 200-ms depolarization, and solid symbols were obtained with a 50-ms
depolarization. The lines correspond to ﬁt of the mean peak DF/F. All ﬂuorescence versus voltage curves were ﬁt with Eq. 1 except those obtained with the 200
ms depolarization in myotubes expressing b1a(D1–D4)/b2aD5/b1aD5 and b2a(D1–D4)/b2aD5/b1aD5, which were ﬁt with Eq. 2. Curves were ﬁt with the
following parameters (DF/Fmax in DF/F units, V1/2 in mV, and k in mV, respectively). For b1a(D1–D4)/b1aD5/b2aD5:1.9, 7.0, and 9.4 (50 ms), and 2.0, 8.9,
and 10.5 (200 ms). For b1a(D1–D4)/b2aD5/b1aD5: 0.4, 20.3, and 21.4 (50 ms), and 0.5, 11.1, and 7.8 (200 ms). For b2a(D1–D4)/b2aD5/b1aD5: 0.3, 4.9,
and 12.5 (50ms), and 0.9, 16.9, and 9.5 (200 ms). For b2a(D1–D4)/b1aD5/b2aD5: 2.2, 16.3, and 9.9 (50 ms), and 2.3, 5.8, and 6.3 (200 ms).
DHPR b-EC Coupling 937
Biophysical Journal 87(2) 929–942
length dependence, typical of skeletal-type EC coupling. In
contrast, D5ALA expressed Ca21 transients with a drastically
reduced voltage-sensitivity to both pulse protocols. In re-
sponse to large positive potentials, the 200 ms pulse pro-
duces Ca21 transients that were ;6-fold smaller than those
of WT b1a and ;3-fold less than those of D5ALAc. From
these results, we concluded that positions L478-V485-L492
in domain D5 play a critical role in skeletal-type EC
coupling.
DISCUSSION
The main conclusions of this work are that i), carboxyl
terminal amino acids 478–524 of b1a comprising the last
tenth of the sequence, herein identiﬁed as domain b1aD5, are
essential for skeletal-type EC coupling; ii), b1aD5 is
functionally active when next to conserved domain D4
(amino acids 254–477 of b1a); and iii), the heptad repeat
motif L478-V485-L492 present in b1aD5 is a critical
determinant of the EC coupling function. Domain D5 of
b1a is present exclusively in b1a and b1c, and only these
two variants, among variants tested from the four mamma-
lian b-genes (Fig. 1), are capable of restoring skeletal-type
EC coupling (see Beurg et al., 1999b, for b1c, and Sheridan
et al., 2003b, for b1a). A third splice variant of the b1-gene,
namely b1b, is entirely devoid of EC coupling function
(Cheng et al., 2004), and D5 domain of b1b bears no
sequence homology with b1aD5 (Powers et al., 1992). The
data also excluded participation of b1aD1 and b1aD3, which
are two additional divergent regions present in b1a. In other
b-variants, domains D1 and D3 modulate the kinetics of
activation and inactivation of the Ca21 current. However,
until now no function had been attributed to divergent
domain D5 in any variant (Qin et al., 1996; Restituto et al.,
2000; Ahern et al., 2003). The identiﬁcation of b1aD5
underscores the fact that b-subunits, far from ancillary, have
critical tissue-speciﬁc functions that can only be identiﬁed
using homologous cell expression systems.
Our results are consistent with proposed mechanisms of
EC coupling and models of DHPR-RyR1 domain organiza-
tion. Mechanisms of EC coupling have been inﬂuenced by
a mechanical coupling model introduced earlier by Chandler
et al. (1976) and later reﬁned as allosteric coupling (Rios
et al., 1993). In this model, the outward movement of the
voltage sensors during depolarization is coupled to Ca21
release from the sarcoplasmic reticulum by mechanical
torque exerted by the voltage sensors on the foot structure of
RyR1. The actions attributed to the a1S II-III loop borrow
extensively from this idea (Garcia et al., 1994; Wilkens et al.,
2001). However, observations accumulated in recent years
suggest that models based on a single DHPR domain such as
the a1S II-III loop interacting with RyR1, are no longer
tenable. First, the proposed signaling role of the a1S II-III
loop has been seriously questioned (Ahern et al., 2001a).
Second, the biochemical evidence indicates that multiple
domains of a1S interact with RyR1 (El Hayek et al., 1995;
FIGURE 6 Ca21 conductance and Ca21
transients expressed by heptad repeat mutants
in b1 KO myotubes. b1a positions L478,
V485, and V492 were mutated to alanine (b1a
L478A/V485A/V492A). This triple mutation is
labeled D5ALA. b1a positions S481, L488,
and S495 were mutated to alanine (b1a S481A/
L488A/S495A). This triple control mutation is
labeled D5ALAc. Ca21 conductance curves
expressed by WT b1a, D5ALA, and D5ALAc
were ﬁt with Eq. 1 with the following
parameters (Gmax in pS/pF, V1/2 in mV, and
k in mV, respectively). For WT b1a (see Fig.
1); for D5ALA: 123, 24.9, and 5.3; for
D5ALAc: 106, 23.0, and 10.7. The shaded
line in the top right curve corresponds to WT
b1a. In ﬂuorescence curves, open symbols
correspond to peak DF/F obtained with a 200-
ms depolarization and solid symbols were
obtained with a 50-ms depolarization. All
ﬂuorescence versus voltage curves were ﬁt
with Eq. 1 with the following parameters (DF/
Fmax in DF/F units, V1/2 in mV, and k in mV,
respectively). For WT b1a: 2.8, 6.1, and 7.8
(50 ms), and 3.2, 10.2, and 5.7 (200 ms). For
D5ALA: 0.4, 14.6, and 14.4 (50 ms), and 0.7,
18.1, and 12.1 (200 ms). For D5ALAc: 2.1,
13.7, and 7.9 (50 ms), and 2.4, 9.1, and 4.3
(200 ms). The shaded lines in bottom right curve correspond toWT b1a used as a reference. Conductance versus voltage curve for WT b1a shown in this ﬁgure
is the same as in the left panel of Fig. 1. Ca21 transient versus voltage curves from WT b1a are from Sheridan et al. (2003b).
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Leong and MacLennan, 1998; Sencer et al., 2001; Proenza
et al., 2002). Finally, a physical contact between b1a and
RyR1 is almost certain, based on three-dimensional
reconstructions of skeletal DHPR particles (Sherysheva
et al., 2002; Wolf et al., 2003), and the observation that
recombinant b1a speciﬁcally binds to the 3490–3523 region
of RyR1 (Cheng et al., 2004). A b-binding site at this
location is consistent with the position of the b-subunit on
the foot structure of RyR1 according to the Wolf-Grigorieff
model (Wolf et al., 2003). The putative b1a binding region is
just upstream of the CaM binding domain (Yamaguchi et al.,
2001; Zhang et al., 2003), and half the way between the
clamp region and transmembrane pore domains (Samso and
Wagenknecht, 2002). Binding of b1a at this location in
RyR1 could assist DHPR tetrad formation, could strengthen
the docking of the DHPR to RyR1, or could serve to funnel
conformational changes initiated in the voltage sensors into
the pore-forming region of RyR1. None of these possibilities
are mutually exclusive. However, a speciﬁc proposal on the
hierarchy of the signals generated by different domains of
a1S or b1a cannot be speciﬁed at this time. Signals
generated in separate DHPR domains or subunits could
converge onto a single RyR1 domain, or separate DHPR
domains could activate separate RyR1 domains. In sum-
mary, the biochemical and structural data, taken together
with the data in this report, suggest that multiple DHPR
domains might be physically docked to RyR1, and might be
responsible for transmission of the trigger signal from the
DHPR voltage sensor to RyR1.
Our data indicate that the location of b1aD5 next to D4
a critical determinant of the skeletal EC coupling phenotype.
We have attempted to explain this result based on a proposed
model of the domain organization of b-subunits. b-subunits
belong to the MAGUK superfamily composed of a tandem
of PDZ, SH3, and GK domains (Anderson, 1996; Craven
and Bredt, 1998). In all b-variants, a prominent SH3 domain
is present in conserved domain D2, and a nonfunctional GK
domain is prominent in domain D4. PDZ domains are
present in domain D1 of some variants but are weakly
represented in members of the b1 gene (Hanlon et al., 1999).
The atomic structure of the SH3-GK core of the MAGUK
protein PSD-95 has been elucidated at a 2.3 A˚ resolution
(McGee et al., 2001; Tavares et al., 2001). In PSD-95, the
SH3 and GK domains interact extensively via hydrophobic
residues lined up across a cleft separating the two domains.
Our data show that ;90% of the b1a sequence is ‘‘generic’’
in the sense that it can be replaced by sequences present in
the heterologous b2a variant. This generic backbone
includes the D2 and D4 domains, that house SH3 and GK,
respectively. We believe that it is highly unlikely that the
domain organization of the D2–D4 core would be altered in
any of the tested chimeras since this core, according to the
PSD-95 model, is held together by hydrophobic interactions
involving multiple conserved residues in D2 and D4.
However, the location of D5 relative to the D2–D4 core
could change depending on the composition of D5, and this
could produce a change in the EC coupling phenotype. The
b1aD5 domain differs from the b2aD5 domain in several
respects. The b2aD5 tail is bulkier than the b1aD5 tail (185
vs. 47 residues; see Materials and Methods for sequence
alignment), and is predicted to be more hydrophilic (Kyte-
Doolitle index 13.5), and richer in turns (high Chou-
Fasman, Garnier-Robson indices) than b1aD5. For these
reasons, an ‘‘EC coupling-permissive’’ conformation may
not be achievable when b2aD5 replaces b1aD5. Fig. 7
shows models of the domain organization of b1aD5 (in red)
and b2aD5 (in blue) that could account for the change
observed in the EC coupling phenotype. A b1aD5 domain
tightly bound to the D2–D4 core (Fig. 7 A) might facilitate
interaction of the subunit, and the DHPR complex as a whole,
with RyR1. Furthermore, the location of b1aD5 next to D4
might direct sequences fused to the carboxyl terminus of
b1aD5, such as b2aD5, away from the DHPR-RyR1 binding
loci (Fig. 7 B). In contrast, the more ﬂexible and bulkier
b2aD5 domain could hinder interaction of the subunit with
RyR1 (Fig. 7 C), and fusion of b1aD5 to the carboxyl
FIGURE 7 Proposed model of the domain organization of b1a. An EC
coupling ‘‘permissive’’ domain organization of b1a (diagrams A and B)
requires domain b1aD5 (red) to be present immediately downstream from
conserved D4 (yellow). Nonpermissive domain organizations (diagrams C
and D) come about when the bulkier b2aD5 domain (blue) hinders
interaction of the subunit and critical binding partners such as RyR1 (gray).
A core of tightly bound D2 (green) and D4 (yellow) is conserved among all
tested chimeras, consistent with the homology of b-subunits to MAGUK
proteins and the structure of the MAGUK protein PSD-95 (McGee et al.,
2001; Tavares et al., 2001). For the sake of clarity, b1aD5 has been drawn
next to D4. However, according to the PSD-95 structure, b1aD5 may be
located closer to the cleft between D2 and D4 domains. EC coupling
permissive states with b1aD5 next to D4 (A and B) could bind preferentially
to RyR1 (gray), or could facilitate binding of other domains of the DHPR to
RyR1.
DHPR b-EC Coupling 939
Biophysical Journal 87(2) 929–942
terminus of b2aD5 might not correct this situation (Fig. 7D).
The model is consistent with the expected constancy of
the D2–D4 core structure, and could also explain why
heterologous sequences fused to the carboxyl terminus of
b1a, such as green ﬂuorescent proteins, do not alter skeletal
excitation-contraction coupling (Neuhuber et al., 1998;
Bhattacharya, et al., 2004; Leuranguer et al., 2004). Finally,
it is important to acknowledge that the proposed model of the
domain organization of b1a pertains to an EC coupling
permissive state achieved when b1aD5 is next to D4. It is
entirely possible that the EC coupling permissive state re-
ﬂects a preferential folding pattern of the b1a subunit that
facilitates binding of the DHPR to RyR1 regardless of
whether b1a is tightly bound to RyR1 or not. The latter
possibility remains to be conﬁrmed by in vitro binding ap-
proaches (Cheng et al, 2004).
Evidence that b1aD5 could be engaged in protein-protein
interactions relates to the ﬁnding of a hydrophobic heptad
repeat motif in that region, which when modiﬁed, drastically
altered the EC coupling phenotype. Secondary structure
predictions using SOMP, PROFPRED, HNN, and other
web-based programs indicated that some of the heptad repeat
positions fall in a-helical regions, although none of the
programs made predictions for the entire 14-residue stretch
covering the three positions in the repeat. Hence, we are not
entirely sure at this point if the identiﬁed positions have the
secondary structure of canonical leucine zippers (Landschulz
et al., 1988). We believe this may be the case since mutation
of the three positions in the heptad repeat produced a drastic
reduction in Ca21 transient amplitude; however, mutation
of 3 positions out of step with the heptad repeat were
phenotypically neutral. The control mutations did not affect
the magnitude of the Ca21 transients relative to WT b1a, and
furthermore, charge movement densities were the same in
D5ALA, the control triple mutant D5ALAc, and WT b1a
(Table 1). Thus, explanations for the change in phenotype
based on a mistargeting of DHPRs to sites away from the cell
surface are unlikely. Leucine-valine heptad repeats are well-
known motifs engaged in protein-protein interactions and
oligomerization (Simmerman et al., 1996; Surks et al., 1999).
Studies have shown the presence of functionally signiﬁcant
leucine/isoleucine heptad repeats downstream from S4 in
each of the four internal repeats of a1S, and at several
locations in RyR1 (Garcia et al., 1997; Marx et al., 2001).
Inspection of the RyR1 sequence indicates two ﬁve-position
hydrophobic heptad repeats in region R9 and three four-
position repeats in region R10 (see Hakamata et al., 1992, for
sequence comparison). RyR1 regions R9 and R10 have been
implicated in skeletal-type excitation-contraction coupling
(Nakai et al., 1998b). In addition, a highly conserved heptad
repeat motif is present in domain D2 of all b-variants (see
Perez-Reyes and Schneider, 1994, for a sequence compar-
ison). Thus, in principle, there could be three potential
targets for the b1aD5 ‘‘hemi-zipper’’: the voltage sensor,
domain D2 in the same subunit, or RyR1. Interactions with
the voltage sensor itself are unlikely since the D5-ALA
mutant does not affect charge movements, and furthermore,
the heptad repeat is not a molecular determinant of Ca21
current expression (see Table 2; Ahern et al., 2003).
However, interactions with D2 or RyR1 may be equally
signiﬁcant in light of the proposed domain organization
model (Fig. 7). Hence, the heptad repeat may be required for
intramolecular SH3-GK interactions, or may form part of
a ‘‘molecular hook’’ engaged in binding other partners.
Whether the heptad repeat is the sole motif in b1aD5
required for EC coupling recovery was not resolved in this
study. Further studies are required to clarify if the heptad
repeat acts alone or in concert with other motifs present in
b1aD5.
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